Cancer drugs: high prices and inequality

The report prepared by No es Sano confirms that cancer treatments are one of the groups of drugs with the highest prices and that generate the most income for the pharmaceutical industry. However, there is a significant public investment in the research phases and in the clinical trials of many of the drugs that remains invisible.